Furthermore, BOK-deficient HCC cells and MEF proliferated slower compared to BOK proficient cells, which is in line with the growth defect reported in the study of Srivastava et al. (2019) and others (Ray et al., 2010; Moravcikova et al., 2017; Zhang et al., 2019). This evidence concerns the gene BOK and hepatocellular carcinoma.